SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Charts for Quick CASH $$$

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (6077)2/5/1998 11:59:00 AM
From: scaram(o)uche  Read Replies (1) of 9262
 
[ TRPS, HYSQ ]

Both moving further. These are plays that are peripheral to the "consolidation in pharma" theme. I've discussed HYSQ, and its relationship to Glaxo/SKB (enthusiasm concerning AFFX and HGSI). Similarly, PCOP purchased Molecular Simulations to cover ground in the drug discovery process. Thus the TRPS move. Given this rationale, some of the worry about the quality of TRPS earnings goes *poof*, and there's no reason why further volume shouldn't show up. Hope it does, as this new rationale could power it through resistance.

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext